1. Castle, M. C., Lage, G. L.: Enhanced biliary excretion of digitoxin following spironolactone as it relates to the prevention of digitoxin toxicity. Res. Commun. Chem. Pathol. Pharmacol. 5, 99?108 (1973)
2. Castle, M. C., Lage, G. L.: Cleavage by ?-glucuronidase of the watersoluble metabolites of digitoxin excreted in the bile of control and spironolactone-pretreated rats. Toxicol. Appl. Pharmacol. 27, 641?647 (1974)
3. Feller, D. R., Gerald, M. C.: Interaction of spironolactone with hepatic microsomal drug metabolizing enzyme systems. Biochem. Pharmacol. 20, 1991?2000 (1971)
4. Greenberger, N. J., Thomas, E. B.: Biliary excretion of 3H-digitoxin. Modification by bile salts and phenobarbital. J. Lab. Clin. Med. 81, 241?251 (1973)
5. Klaassen, C. D.: Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides. J. Pharmacol. Exp. Ther. 191, 201?211 (1974)